Role of the immune system in hypertension: modulation by dietary antioxidants.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 3331645)

Published in Int J Angiol on December 01, 2011

Authors

Sudesh Vasdev1, Jennifer Stuckless, Vernon Richardson

Author Affiliations

1: Discipline of Medicine, Health Sciences Centre, Memorial University, St. John's, Newfoundland, Canada.

Articles cited by this

(truncated to the top 100)

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93

TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 17.49

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med (2005) 10.88

NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res (2000) 8.62

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res (1994) 8.57

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol (2006) 7.84

Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med (2007) 7.69

Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes (2002) 7.17

Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation (2005) 7.04

Role of oxidative modifications in atherosclerosis. Physiol Rev (2004) 6.73

The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol (2004) 6.44

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest (2003) 6.30

A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol (2008) 6.09

C-reactive protein and the risk of developing hypertension. JAMA (2003) 5.75

Blood pressure and end-stage renal disease in men. N Engl J Med (1996) 5.68

A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science (2008) 5.28

Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res (2007) 4.92

Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A (2006) 4.10

Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol (2006) 4.07

Insulin resistance in essential hypertension. N Engl J Med (1987) 3.78

Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr (2004) 3.61

Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev (2010) 3.60

Inflammation, immunity, and hypertension. Hypertension (2010) 3.43

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab (2000) 3.42

Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am J Physiol Heart Circ Physiol (2005) 3.22

A link between polymorphonuclear leukocyte intracellular calcium, plasma insulin, and essential hypertension. Am J Hypertens (2002) 3.10

SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J Biol Chem (2001) 3.09

Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension (2009) 3.06

Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol (2002) 3.04

RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol (2005) 2.96

Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord (2003) 2.94

Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem (1998) 2.92

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab (2001) 2.91

Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology (2006) 2.82

The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem (2008) 2.72

Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol (2009) 2.70

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem (2003) 2.67

SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem (2000) 2.61

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation (2000) 2.59

Blood pressure and inflammation in apparently healthy men. Hypertension (2001) 2.55

Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol (2004) 2.46

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes (2003) 2.40

Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr (2006) 2.24

Redox-dependent transcriptional regulation. Circ Res (2005) 2.23

Alcohol, oxidative stress, and free radical damage. Alcohol Res Health (2003) 2.19

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia (2007) 2.19

Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit Rev Toxicol (2005) 2.13

Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland. Am J Epidemiol (2004) 2.08

Selenium biochemistry. Annu Rev Biochem (1990) 2.08

Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol (2000) 2.07

Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci U S A (2009) 2.07

Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest (1994) 2.06

TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest (2006) 2.04

Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr (1991) 2.01

Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol (2008) 1.98

Role of cysteine residues in regulation of p53 function. Mol Cell Biol (1995) 1.91

Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol (2002) 1.89

A role for oxidized phospholipids in atherosclerosis. N Engl J Med (2005) 1.89

Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr (2005) 1.88

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest (1997) 1.88

Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation (1998) 1.86

RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts. J Leukoc Biol (2009) 1.84

Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension (2004) 1.83

C-reactive protein concentration and incident hypertension in young adults: the CARDIA study. Arch Intern Med (2006) 1.81

Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation (2004) 1.81

Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation (1993) 1.81

Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest (1999) 1.80

Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension (1991) 1.78

Role of proinflammatory cytokines and redox homeostasis in exercise-induced delayed progression of hypertension in spontaneously hypertensive rats. Hypertension (2009) 1.74

Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol (2007) 1.74

Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol (2005) 1.72

Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am J Physiol Renal Physiol (2008) 1.71

H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem (2001) 1.68

Vascular Angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats. Hypertens Res (2007) 1.67

Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol (2007) 1.65

Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension (2006) 1.65

Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr (2000) 1.64

Systemic inflammation, metabolic syndrome and progressive renal disease. Nephrol Dial Transplant (2009) 1.63

Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress. Arterioscler Thromb Vasc Biol (2009) 1.63

Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med (2007) 1.62

Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler Thromb Vasc Biol (2005) 1.62

Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res (1998) 1.60

Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens (2004) 1.58

Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension (2006) 1.53

Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res (2003) 1.53

Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens (1998) 1.51

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int (2001) 1.50

Insulin stimulates glyceraldehyde-3-phosphate dehydrogenase gene expression through cis-acting DNA sequences. Proc Natl Acad Sci U S A (1988) 1.49

Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci (2003) 1.49

Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab (2000) 1.48

Fructose induces the inflammatory molecule ICAM-1 in endothelial cells. J Am Soc Nephrol (2008) 1.46

Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. J Am Diet Assoc (2009) 1.46

Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension (1997) 1.45

Angiotensin II and vascular inflammation. Med Sci Monit (2005) 1.44

Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest (1990) 1.42

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol (2001) 1.42

Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol (1991) 1.39

Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr (2009) 1.35

Epidemiology and prevention of hypertension. Med Clin North Am (1997) 1.35

Articles by these authors

Antihypertensive effects of dietary protein and its mechanism. Int J Angiol (2010) 0.84

Role of methylglyoxal in essential hypertension. Int J Angiol (2010) 0.81